Table 1. List of APOL1 odds ratio studies.
Study | Year | Author | Population | OR |
---|---|---|---|---|
Case-control | 2010 | Genovese(87) | FSGS1(USA) | 10.5 |
Case-control | 2010 | Genovese(87) | ESRD-HTN (USA) | 7.3 |
Case-control | 2010 | Tzur(15) | ESRD-HTN2 | 4.9 |
Case-control | 2011 | Kopp(17) | HIVAN1 (USA) | 29.2 |
Case-control | 2011 | Kopp(17) | FSGS1 (USA) | 16.9 |
Case-control | 2011 | Papeta(88) | FSGS1 (USA) | 3 |
Case-control | 2011 | Papeta(88) | HIVAN1 (USA) | 3 |
Populational | 2011 | Friedman(29) | Dallas Heart Study Malb3 (USA) | 3 |
Populational | 2011 | Friedman(29) | Dallas Heart Study CKD1 (USA) | 4 |
Case-control | 2012 | Fine(89) | HIV1 (USA) | 3 |
Coorte ESRD | 2012 | Lipkowitz(90) | AASK CKD1(USA) | 4 |
Coorte ESRD | 2012 | Lipkowitz(90) | AASK proteinuria1 (USA) | 6 |
Coorte ESRD | 2012 | Lipkowitz(90) | AASK1 (USA) | 3 |
Case-control | 2013 | Ulasi(91) | CKD1 (Nigeria) | 6 |
Coorte ESRD | 2013 | Parsa(26) | AASK progressionESRD1 (USA) | 2 |
Coorte ESRD | 2013 | Parsa(26) | CRIC progression CKD4 (USA) | 3 |
Populational | 2013 | Foster(92) | ARIC - CKD5 (USA) | 2 |
Populational | 2013 | Foster(92) | ARIC - ESRD1 (USA) | 3 |
1 = only African descendants with CKD
2 = African descendants and Hispanics with CKD
3 = general population
4 = general population with CKD
5 = general African descendants